10.1016/j.appet.2022.106022 [DOI] [PMC free article] [PubMed] [Google Scholar] Song S., Guo R., Mehmood A., Zhang L., Yin B., Yuan C., et al
Approximately 49,000 members, representing 3.6 percent of the total insured population, were actively using GLP-1 medications
In adults with obesity, along with diet and exercise, Nausea was generally transient 4 Most occurrences of nausea did not lead to permanent discontinuation of Wegovy HD STEP UP: Reported nausea (median duration 6 days) In STEP UP, nausea was reported in all treatment arms and was most prevalent during the dose-escalation period 4 Nausea was not prospectively measured at each patient visit in clinical trials
They have dropped 24% since researchers released the study in July, as of the Dec
Since June 2023, Humana requires pharmacies to submit ICD-10 codes for GLP-1 claims
GLP-1 medications work by supporting the bodys natural appetite and fullness signals